Skip to main content
Jeffrey Weber, MD, Oncology, New York, NY, NYU Langone Hospitals

JeffreySWeberMD

Oncology New York, NY

Physician

Dr. Weber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Weber's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterInternship, Internal Medicine, 1980 - 1981
  • New York University School of Medicine
    New York University School of MedicineClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1994 - Present
  • NY State Medical License
    NY State Medical License 1983 - 2025
  • FL State Medical License
    FL State Medical License 2007 - 2017
  • MD State Medical License
    MD State Medical License 1985 - 1995
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Society for Immunotherapy of Cancer Perspective on Regulation of Interleukin-6 Signaling in COVID-19-Related Systemic Inflammatory Response  
    Steven J O'Day, Walter J Urba, Jeffrey S Weber, Journal For Immunotherapy of Cancer

Lectures

  • Serum IL-6 and CRP as prognostic factors in melanoma patients receiving single agent and combination checkpoint inhibition. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage III/IV melanoma: Updated results from a phase III trial (CheckMate 238). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • NYU Langone Health in the News—Monday, May 8, 2023
    NYU Langone Health in the News—Monday, May 8, 2023May 8th, 2023
  • Personalized mRNA Vaccine Boosts Immunotherapy for High-Risk Melanoma
    Personalized mRNA Vaccine Boosts Immunotherapy for High-Risk MelanomaApril 19th, 2023
  • Merck’s Keytruda Scores Triple Hit at AACR
    Merck’s Keytruda Scores Triple Hit at AACRApril 19th, 2023
  • Join now to see all

Professional Memberships

Hospital Affiliations